Horizon BCBS NJ Viscosupplements prior authorization requirements (2026)
What Horizon BCBS NJ generally requires to approve Viscosupplements (CPT J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332). Yes. Horizon BCBS NJ generally requires prior authorization for Viscosupplements (CPT J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332).
Medical-necessity criteria Horizon BCBS NJ generally applies
Prior authorization required; managed via the Horizon Medical Injectables Program (MIP), administered by MagellanRx Management - NOT TurningPoint (surgical) or eviCore (imaging). Governed by Horizon's own Policy 015 (Sodium Hyaluronate Injections). Covered for knee osteoarthritis ONLY (other joints investigational). Preferred agents (Synvisc, Synvisc-One, Orthovisc, Euflexxa, Monovisc) for mild-to-moderate knee OA require (all): diagnosis of mild-to-moderate OA (Kellgren-Lawrence grade 1-3) of the knee confirmed by a rheumatologist, orthopedic surgeon, or orthopedist; failure to respond adequately to conservative nonpharmacologic therapy; trial/intolerance/contraindication to simple analgesics with no functional improvement after at least 3 months; and no contraindications (e.g., active joint infection, bleeding disorder). Severe OA (grade 4): the above plus not a candidate for total knee replacement due to risk factors. Non-preferred agents additionally require documented failure/contraindication/hypersensitivity to at least one preferred agent. Repeat series allowed every 6 months only with documented significant pain/function improvement and analgesic dose reduction from the prior course. Quoted from Horizon Policy 015.
Related procedure codes
Codes often billed alongside Viscosupplements: J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332. Verify the correct codes for your documentation.
Commonly required documentation
- Radiographic confirmation of knee OA grade (KL 1-4)
- documentation of failed conservative nonpharmacologic therapy
- at least a 3-month trial/intolerance/contraindication to simple analgesics
- diagnosing specialty (rheumatologist/orthopedic surgeon/orthopedist)
- for non-preferred agents, prior failure/contraindication to >=1 preferred agent
- for a repeat series, documented improvement + analgesic reduction and >=6 months since the prior course.
Situations to verify before submitting
Horizon BCBS NJ may not cover Viscosupplements in these situations. Verify against the current policy rather than assuming a denial:
- Sodium hyaluronate injections administered to joints other than the knee in osteoarthritis - investigational
- Administration to any joint for conditions/diseases other than knee OA - investigational
- Repeat series within 6 months, or without documented response and analgesic dose reduction - not medically necessary
How to submit
- Method: portal
- Portal: Horizon Medical Injectables Program (MagellanRx)
Sources & verification
- BindingPayer medical policy — Horizon Policy 015 - Sodium Hyaluronate Injections (015) · effective 2020-08-21.View
- BindingPayer medical policy — Horizon Medical Injectables Program (administered by MagellanRx Management).View
Binding = the payer's own policy. Proxy = a public, evidence-based clinical guideline the payer mirrors. Portal-only = the binding criteria are confirmed in the administrator's portal. Always confirm against the payer for the member's specific plan. Last verified 2026-06-20.
Frequently asked questions
Does Horizon BCBS NJ require prior authorization for Viscosupplements?
Yes. Horizon BCBS NJ generally requires prior authorization for Viscosupplements (CPT J7318, J7320, J7321, J7322, J7323, J7324, J7325, J7326, J7327, J7328, J7329, J7331, J7332).
What does Horizon BCBS NJ require to approve Viscosupplements?
Prior authorization required; managed via the Horizon Medical Injectables Program (MIP), administered by MagellanRx Management - NOT TurningPoint (surgical) or eviCore (imaging). Governed by Horizon's own Policy 015 (Sodium Hyaluronate Injections). Covered for knee osteoarthritis ONLY (other joints investigational). Preferred agents (Synvisc, Synvisc-One, Orthovisc, Euflexxa, Monovisc) for mild-to… Always confirm against the current Horizon BCBS NJ policy.
How long does a Horizon BCBS NJ prior authorization take?
Turnaround varies by plan and submission method. Check the Horizon BCBS NJ portal for current timeframes.
Submitting Viscosupplements to Horizon BCBS NJ?
Praxigen checks your clinical note against these criteria before you submit and drafts a policy-cited appeal if it is denied. You review and submit; nothing is sent automatically.